These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 14890823)

  • 1. Effect of combined therapy (dihydrostreptomycin and PAS) on the emergence of streptomycin-resistant strains of tubercle bacilli.
    SHANE SJ; LAURIE JH; RILEY C; BOUTILIER M
    N Engl J Med; 1952 Jan; 246(4):132-4. PubMed ID: 14890823
    [No Abstract]   [Full Text] [Related]  

  • 2. Laboratory and other basic research: the effect of PAS on the emergence of tubercle bacilli resistant to dihydrostreptomycin; a U.S. Public Health Service investigation.
    BECK F
    Trans Annu Meet Natl Tuberc Assoc; 1951; 47():77-87. PubMed ID: 14893363
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of para-aminosalicylic acid (PAS) on the development of resistance of tubercle bacilli to streptomycin.
    FRIEDMAN B; SALE L; GOLDMAN A
    Am J Med Sci; 1952 Jul; 224(1):53-6. PubMed ID: 14933413
    [No Abstract]   [Full Text] [Related]  

  • 4. The frequency of drug resistant tubercle bacilli following administration of dihydrostreptomycin and paraaminosalicylic acid three days per week.
    KARISON AG; CARR DT; HOFMANN GN; PFUETZE KH
    Proc Staff Meet Mayo Clin; 1951 Nov; 26(23):437-40. PubMed ID: 14883205
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative in vitro response of tubercle bacillus (H37RV) to dihydrostreptomycin, para-aminosalicylic acid, and dihydrostreptomycin-para-aminosalicylate.
    VENNESLAND K; ALTONA J; BLOCH RG
    Proc Soc Exp Biol Med; 1950 Nov; 75(2):436-8. PubMed ID: 14808284
    [No Abstract]   [Full Text] [Related]  

  • 6. RESISTANT tubercle bacilli.
    Lancet; 1957 Apr; 272(6973):825-6. PubMed ID: 13417612
    [No Abstract]   [Full Text] [Related]  

  • 7. [Resistance of the tubercle-bacillus to drugs in general and PAS in particular].
    DE BEULE R
    Schweiz Z Tuberk; 1952; 9(2):76-85. PubMed ID: 14958380
    [No Abstract]   [Full Text] [Related]  

  • 8. DRUG resistance of tubercle bacilli following antibiotic treatment.
    S Afr Med J; 1952 Jul; 26(29):585. PubMed ID: 12984191
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental studies on the synergic effect of antituberculous agents. III. Influence of the combined application of antituberculous agents on the resistance of in vivo tubercle bacilli.
    MIZUNO M
    Kekkaku; 1953 Jul; 28(7):356-7. PubMed ID: 13085554
    [No Abstract]   [Full Text] [Related]  

  • 10. [A new rapid determination method of resistance applying the color reaction of tubercle bacilli].
    KAWAI K
    Kekkaku; 1955 Nov; 30(11):621-7. PubMed ID: 13286843
    [No Abstract]   [Full Text] [Related]  

  • 11. [APPRAISAL OF PRESENT METHODS OF TESTING TUBERCLE BACILLI RESISTANCE. (3). ON VARIOUS FACTORS INFLUENCING THE FINDINGS ON THE DISTRIBUTION OF RESISTANT BACILLI IN RESISTANCE TESTS].
    YOSHIHARA N
    Kyoto Daigaku Kekkaku Kenkyusho Kiyo; 1964 Mar; 12():129-42. PubMed ID: 14161653
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the effect of para-aminosalicylic acid on tubercle bacilli, and the occurrence of PAS-resistant strains.
    ESPERSEN E
    Acta Pathol Microbiol Scand; 1951; 29(3):263-76. PubMed ID: 14933027
    [No Abstract]   [Full Text] [Related]  

  • 13. [Streptomycin and PAS resistance of tubercle bacteria isolated from patients with tuberculous meningitis].
    VAN ZEBEN W; VAN GENDEREN H; MANTEN A
    Maandschr Kindergeneeskd; 1952 Apr; 20(3):69-83. PubMed ID: 14940043
    [No Abstract]   [Full Text] [Related]  

  • 14. RESISTANT tubercle bacilli.
    Lancet; 1953 Aug; 265(6779):237-9. PubMed ID: 13070606
    [No Abstract]   [Full Text] [Related]  

  • 15. The mechanism of action of para-aminosalicylic acid in preventing the emergence of resistance to streptomycin in mycobacterium tuberculosis.
    TSUKAMURA M
    J Antibiot (Tokyo); 1955 Dec; 8(6):196-200. PubMed ID: 13319223
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of combined therapy with streptomycin, para-aminosalicylic acid and promin on the emergence of streptomycin-resistant strains of tubercle bacilli; a preliminary report.
    KARLSON AG; PFUETZE KH
    Proc Staff Meet Mayo Clin; 1949 Feb; 24(4):85-8. PubMed ID: 18112754
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of combined treatment with streptomycin, PAS and isoniazid on resistance of Mycobacterium tuberculosis to streptomycin and isoniazid].
    JANKOV M
    Hig Cas Hig Mikrobiol Epidemiol Sanit Teh; 1955; 7(1-4):228-34. PubMed ID: 13405406
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of solid and liquid medium sensitivity tests of tubercle bacilli to para-aminosalicylic acid.
    MITCHISON DA; MONK M
    J Clin Pathol; 1955 Aug; 8(3):229-36. PubMed ID: 13252105
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study on infection with drug resistant tubercle bacilli from patients among the already tuberculin-positive persons without tuberculous lesions in a workshop].
    KOIKE S; MURASE S; OOMI A
    Kekkaku; 1962 Apr; 37():188-94. PubMed ID: 14457874
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic considerations of the mechanisms involved in PAS-resistant tubercle bacilli.
    TSUKAMURA M; NODA Y; YAMAMOTO M; HAYASHI M
    Am Rev Tuberc; 1959 Mar; 79(3):371-3. PubMed ID: 13627446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.